Bicycle Therapeutics plc (50BA) - Total Liabilities

Latest as of December 2025: €107.62 Million EUR ≈ $125.82 Million USD

Based on the latest financial reports, Bicycle Therapeutics plc (50BA) has total liabilities worth €107.62 Million EUR (≈ $125.82 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 50BA cash generation efficiency to assess how effectively this company generates cash.

Bicycle Therapeutics plc - Total Liabilities Trend (2018–2025)

This chart illustrates how Bicycle Therapeutics plc's total liabilities have evolved over time, based on quarterly financial data. See 50BA book value for net asset value and shareholders' equity analysis.

Bicycle Therapeutics plc Competitors by Total Liabilities

The table below lists competitors of Bicycle Therapeutics plc ranked by their total liabilities.

Company	Country	Total Liabilities
Jiangsu Zhongshe Group Co Ltd SHE:002883	China	CN¥204.10 Million
Panca Budi Idaman Tbk PT JK:PBID	Indonesia	Rp535.64 Billion
Starz Entertainment LLC NASDAQ:STRZ	USA	$1.27 Billion
Ingram Micro Bilisim Sistemleri A.S. IS:INGRM	Turkey	TL7.23 Billion
Alvopetro Energy V:ALV	Canada	CA$23.67 Million
908 Devices Inc NASDAQ:MASS	USA	$46.37 Million
Salmon Evolution Holding AS OL:SALME	Norway	Nkr1.75 Billion
Sonmez Filament Sentetik Iplik ve Elyaf Sanayi AS IS:SONME	Turkey	TL675.76 Million

Liability Composition Analysis (2018–2025)

This chart breaks down Bicycle Therapeutics plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Bicycle Therapeutics plc worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	11.98	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.18	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.15	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bicycle Therapeutics plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bicycle Therapeutics plc (2018–2025)

The table below shows the annual total liabilities of Bicycle Therapeutics plc from 2018 to 2025.

Year	Total Liabilities	Change
2025-12-31	€107.62 Million ≈ $125.82 Million	-34.30%
2024-12-31	€163.81 Million ≈ $191.51 Million	-27.01%
2023-12-31	€224.41 Million ≈ $262.36 Million	+60.49%
2022-12-31	€139.83 Million ≈ $163.47 Million	+4.71%
2021-12-31	€133.54 Million ≈ $156.12 Million	+103.28%
2020-12-31	€65.69 Million ≈ $76.80 Million	+286.51%
2019-12-31	€17.00 Million ≈ $19.87 Million	-88.78%
2018-12-31	€151.45 Million ≈ $177.06 Million	--

About Bicycle Therapeutics plc

F:50BA Germany Biotechnology

Market Cap

$230.38 Million

€197.05 Million EUR

Market Cap Rank

#16008 Global

#1530 in Germany

Share Price

€3.92

Change (1 day)

+0.51%

52-Week Range

€3.62 - €8.45

All Time High

€52.00